4//SEC Filing
Aevi Genomic Medicine, Inc. 4
Accession 0001192482-17-000046
CIK 0001138776operating
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 5:43 PM ET
Size
5.6 KB
Accession
0001192482-17-000046
Insider Transaction Report
Form 4
Piper Brian
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Purchase)
2017-02-17+190,000→ 190,000 totalExercise: $4.91Exp: 2027-02-17→ Common Stock (190,000 underlying)
Footnotes (1)
- [F1]The option award vests and becomes exercisable in three equal installments (rounded up to the nearest whole share of common stock) on February 17, 2018, February 17, 2019 and February 17, 2020, subject to the reporting person's continued service with the issuer.
Documents
Issuer
Aevi Genomic Medicine, Inc.
CIK 0001138776
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001138776
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 5:43 PM ET
- Size
- 5.6 KB